Take 5 minutes to catch up on NeurologyLive's highlights from the week ending April 9, 2021.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
In this Peer Exchange series, "Management of Progressive Multiple Sclerosis," experts in MS care including Bruce Cree, MD, PhD; Joseph R. Berger, MD; Kristen Krysko, MD; Fred D. Lublin, MD; and Robert Fox, MD, discuss patient selection for drugs based on disease activity.
The consultant in the department of neurology at Mayo Clinic detailed a number of topics surrounding Parkinson Disease Awareness Month, including the progress made in the last 2 decades.
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Bhooma Aravamuthan, MD, DPhil, who recently completed a survey of child neurologists and neurodevelopmentalists regarding their inclusion in the diagnosis of individuals with cerebral palsy, about the findings and the current status of care for the condition.
Patients with a history of abuse reported a higher average or median questionnaire scores that focused on anxiety, depression, photophobia, hyperacusis, ictal allodynia, and interictal allodynia.
In this CURE Connections series, "Strategies for Managing Progressive Multiple Sclerosis During COVID-19," features Mary Ann Picone, MD, and June Halper, MSN, MSCN, and an individual with MS as they discuss the incorporation of televisits for multiple sclerosis during COVID-19.